EMA Outlines High-Level Strategy for Next Five Years
The EMA has released their network strategy for the next five years which covers topics such as: human health promoting … read more »
2016 PPRS Payment Percentage
The Department of Health has today announced the level of payment due from members of the Pharmaceutical Price Regulation Scheme … read more »
AEMPS end of year summary
The Spanish Medicines Agency, AEMPS, ended 2015 with a total number of 66 therapeutic positioning reports (IPTs), published in 34 … read more »
EU portal and database update
The EMA Management Board have endorsed the time frame for implementation of the EU clinical trial portal and database. This … read more »
NHS England announces budget allocation for the next five years
The NHS England Board have released a paper outlining their planned allocation of resources to NHS England and the commissioning … read more »
Updated vanguard support package published
A revised national support package for 50 vanguards has been published by the NHS Five Year Forward partners. The updated … read more »
Smarter regulation could result in lower drug prices says EMA Executive Director
Guido Rasi, the Executive Director of the European Medicines Agency (EMA), has stated in a virtual press briefing that the EMA … read more »
EMA takes a firmer stance on good clinical practice non-compliance
The European Medicines Agency (EMA) have released a new position paper on the non-acceptability of replacement of pivotal clinical trials during … read more »
New medicines manufacturing landscape portal launched
A new web portal has been launched to promote the UK’s strengths and capabilities in medicines manufacturing. Developed by the … read more »
Public Accounts Committee – Cancer Drugs Fund
A Public Accounts Committee session was held on 30th November 2015 to challenge the Department of Health (DH) and NHS England on the … read more »
